RecruitingNCT06507878

Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.

Sponsor

M.D. Anderson Cancer Center

Enrollment

459 participants

Start Date

Dec 5, 2024

Study Type

OBSERVATIONAL

Conditions

Thyroid Cancer

Summary

The goal of this clinical research study is to learn about the barriers in the real world to accessing treatments for ATC. And to learn about how patients with ATC tolerate and respond to the commercially available medications for treatment of this disease, outside of a clinical study.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a global patient registry — a large observational study — for people with advanced or aggressive forms of thyroid cancer (specifically anaplastic or poorly differentiated thyroid cancer). The goal is to collect real-world data on how these patients are treated and how well those treatments work. **You may be eligible if...** - You are 18 years of age or older (21 or older in some countries, such as Singapore) - You have been clinically or pathologically diagnosed with anaplastic thyroid cancer or poorly differentiated thyroid cancer **You may NOT be eligible if...** - Your tumor biopsy results do not confirm anaplastic or poorly differentiated thyroid cancer Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.